<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Prohibited activities</p><ul class="Section ProvisionList" id="1174035"><li><p class="Subsection" id="1174037"><strong><a class="sectionLabel" id="s-21.9"><span class="sectionLabel">21.9</span></a></strong> <span class="lawlabel">(1)</span> No person shall import, sell, advertise, manufacture, prepare, preserve, package, label, store or test an advanced therapeutic product unless the person</p><ul class="ProvisionList"><li><p class="Paragraph" id="1174038"><span class="lawlabel">(a)</span> holds a licence in respect of that product that was issued under subsection 21.92(1) and that authorizes the activity in question;</p></li><li><p class="Paragraph" id="1174039"><span class="lawlabel">(b)</span> is authorized under an order made under subsection 21.95(1) to conduct the activity in question in respect of the product; or</p></li><li><p class="Paragraph" id="1174040"><span class="lawlabel">(c)</span> conducts the activity in question in accordance with the regulations.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Clarification</p><p class="Subsection" id="1174041"><span class="lawlabel">(2)</span> For greater certainty, the prohibition applies in respect of an activity regardless of whether the activity is conducted for the purpose of the sale or use of the advanced therapeutic product.</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem"><a href="#1156064-1174044" aria-controls="centred-popup" class="wb-lbx" role="button" data-ajax-after="1156064-1174044.html">2019, c. 29, s. 169</a></li></ul></div>
